Cargando…

Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis

In order to ascertain the incidence and prognosis of cisplatin-induced neurotoxicity in testis cancer patients undergoing combination chemotherapy, 29 patients with metastatic disease were studied prospectively. Assessments included enquiry into neurological symptoms, measurement of sural nerve sens...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schlippe, M von, Fowler, C J, Harland, S J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375074/ https://www.ncbi.nlm.nih.gov/pubmed/11556831 http://dx.doi.org/10.1054/bjoc.2001.2006

Ejemplares similares

Human germ cell tumours: expression of γ-glutamyl transpeptidase and sensitivity to cisplatin
por: Hanigan, M H, et al.
Publicado: (1999)

Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours
por: Fosså, S D, et al.
Publicado: (1999)

Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin
por: Mitry, E, et al.
Publicado: (1999)

Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT)
por: Bono, J S de, et al.
Publicado: (2000)

Risk factors for testicular germ cell tumours by histological tumour type
por: Coupland, C A C, et al.
Publicado: (1999)

An orthotopic xenograft model of human nonseminomatous germ cell tumour
por: Douglas, M L, et al.
Publicado: (2001)

A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma
por: Horwich, A, et al.
Publicado: (2000)

Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse
por: Hain, S F, et al.
Publicado: (2000)

Cisplatin anti-tumour potentiation by tirapazamine results from a hypoxia-dependent cellular sensitization to cisplatin
por: Kovacs, M S, et al.
Publicado: (1999)

Identification of tumour-associated and germ line p53 mutations in canine mammary cancer
por: Veldhoen, N, et al.
Publicado: (1999)

Lack of Bcl10 mutations in testicular germ cell tumours and derived cell lines
por: Schothorst, E M van, et al.
Publicado: (1999)

Is CBOP/BEP an alternative to BEP for patients with poor prognosis metastatic germ cell tumours?
por: Addeo, A, et al.
Publicado: (2016)

Chromosomal imbalances associated with carcinoma in situ and associated testicular germ cell tumours of adolescents and adults
por: Summersgill, B, et al.
Publicado: (2001)

Surgery in metastatic non-seminomatous germ cell tumours.
por: Tobias, J. S.
Publicado: (1992)

Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours
por: Marks, A, et al.
Publicado: (1999)

Prediction of relapse after lymph node dissection for germ cell tumours: can salvage chemotherapy be avoided?
por: Berney, D M, et al.
Publicado: (2001)

Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: a single-institution experience.
por: Gerl, A., et al.
Publicado: (1996)

Long-term follow-up of residual masses after chemotherapy in patients with non-seminomatous germ cell tumours
por: Napier, M P, et al.
Publicado: (2000)

Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour
por: Johnson, P J, et al.
Publicado: (1999)

Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin
por: C̆emaz̆ar, M, et al.
Publicado: (1999)

The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).
por: Peckham, M. J., et al.
Publicado: (1983)

Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: evidence suggestive of the linear progression model
por: Faulkner, S W, et al.
Publicado: (2000)

Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa
por: Staff, S, et al.
Publicado: (2001)

Sequential detection of alphafetoprotein-bearing cells in blood stem cell fraction of germ cell tumour patients
por: Kasahara, T, et al.
Publicado: (2001)

Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours
por: Cierna, Zuzana, et al.
Publicado: (2020)

Relationship of hypoxia to metastatic ability in rodent tumours
por: Jaeger, K De, et al.
Publicado: (2001)

Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours
por: Anthoney, D A, et al.
Publicado: (2004)

Prognosis after salvage treatment for unselected male patients with germ cell tumours.
por: Gerl, A., et al.
Publicado: (1995)

The effect of carboplatin on renal function in patients with metastatic germ cell tumours.
por: Mason, M. D., et al.
Publicado: (1991)

Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)
por: Dearnaley, D P, et al.
Publicado: (2005)

The changing role of surgery in metastatic non-seminomatous germ cell tumour.
por: Cassidy, J., et al.
Publicado: (1992)

Influence of Nodal signalling on pluripotency factor expression, tumour cell proliferation and cisplatin-sensitivity in testicular germ cell tumours
por: Harpelunde Poulsen, K., et al.
Publicado: (2020)

Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour
por: Rimmer, Y, et al.
Publicado: (2011)

The role of surgery in metastatic testicular germ cell tumours (GCT).
por: Newlands, E. S., et al.
Publicado: (1989)

Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumours
por: Kosmas, C, et al.
Publicado: (2000)

Proteomic profiling of cisplatin-resistant and cisplatin-sensitive germ cell tumour cell lines using quantitative mass spectrometry
por: Fichtner, A., et al.
Publicado: (2022)

Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study
por: Hong, R L, et al.
Publicado: (1999)

A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts
por: Pratesi, G, et al.
Publicado: (1999)

Neurotoxicity associated with colistin methanesulfonate treatment is enhanced by concomitant sevoflurane inhalation
por: Gotoda, Mai, et al.
Publicado: (2022)

Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumours
por: Fleischhack, G, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_ot72br0dk5ea5mua4ivbi43ogt